Advances in Leishmania Vaccines: Current Development and Future Prospects

Andreina Ayala1, Alejandro Llanes1,2, Ricardo Lleonart1,2

  • 1Centro de Biología Celular y Molecular de Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panama City 0843-01103, Panama.

PubMed
Summary

Developing effective vaccines against leishmaniasis is crucial due to drug resistance. Recent advances, like the ChAd63-KH DNA vaccine, show promise for controlling this neglected tropical disease.